Glucose production in liver

The phrase "glucose production in liver" refers to the collective metabolic processes, primarily **gluconeogenesis** and **glycogenolysis**, by which hepatocytes synthesize and release glucose into the bloodstream. This output is essential for maintaining blood glucose homeostasis, especially during fasting or between meals. The rate and magnitude of hepatic glucose production are controlled acutely and chronically by hormonal regulators such as insulin and glucagon, as well as by the activity and expression of key metabolic enzymes (e.g., **phosphoenolpyruvate carboxykinase [PCK1]**, **glucose-6-phosphatase [G6Pase]**, **glucokinase [GK]**, **glycogen phosphorylase**, **glycogen synthase**) and their transcriptional regulators[1][4][7]. Dysregulation of these pathways, particularly their excessive activation, contributes centrally to hyperglycemia in diabetes mellitus[7][5]. Although many drugs (e.g., **metformin**, **SGLT2 inhibitors**) act indirectly to reduce hepatic glucose production, these therapies generally target the enzymes or pathways rather than "glucose production in liver" as a unified molecular entity[7]. Notes on structure and classification: - "Glucose production in liver" is a physiological function resulting from the integrated activity of many molecular targets and regulatory pathways in hepatocytes. - As a result, it cannot be classified as a therapeutic target in the sense of receptors, enzymes, or transporters. - In drug development, commonly referenced individual targets within this process include *PEPCK (phosphoenolpyruvate carboxykinase)*, *G6Pase (glucose-6-phosphatase)*, *GLUT2 (glucose transporter 2)*, and certain G protein-coupled receptors[9]. - Drugs that suppress hepatic glucose production (e.g., *metformin*) do so primarily by acting on molecular regulators (such as mitochondrial complex I, AMPK), rather than directly on "hepatic glucose production" as a discrete entity[7]. - "Glucose production in liver" is therefore not a canonical molecular target and should not be used as such in structured datasets or ontologies. If a specific enzymatic or receptor target within this process is needed (e.g., PCK1, G6PC, or other), please specify for structured details.

Other names

hepatic glucose outputhepatic glucose productionliver glucose production